Diurnal begins Phase I trial of DITEST to treat hypogonadism

UK-based specialist pharmaceutical company Diurnal has begun its Phase I clinical trial of DITEST to treat males with hypogonadism.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news